GSK Eyes Growth in Cancer Drugs Amid Investor Pipeline Concern
GSK Plc is looking to further grow its cancer drug business, a senior executive said, after the drugmaker’s $1.15 billion ...
GSK Pharma hits 3-month high in weak market; surges 32% in 7 days
The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...
GSK’s Sluggish Shares Seen at Risk of New Activist Campaign
GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine ...
GSK struggles to convince market it can deliver on pipeline plans
UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its pipeline ahead of a key patent expiry, as US hedge fund Citadel took the largest short position ...
GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'
GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...
GSK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Shareholders Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...
Daily8h
Dr Gavin Screaton to join Board of GSK as Non-Executive Director
On appointment, Dr Screaton will become a member of the GSK Board Science Committee and the Corporate Responsibility ...
GSK rises Tuesday, outperforms market
GSK PLC closed 20.87% below its 52-week high of £18.24, which the company reached on May 16th.
West Columbus industrial property acquired for $8.1 million
Janitrol OH LP, which is tied to Bloomfield Hills, Michigan-based GSK Industrial, bought the building for $8.1 million. The ...
Hedge fund Citadel takes short position in GSK, FT reports
Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...
FiercePharma3d
PMCPA brings the buzzkill to LinkedIn celebration, laying into GSK over employee’s clicks
The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a prescription drug on LinkedIn.
The Harvard Crimson4d
Biopharma Giant GSK to Expand Research and Development Footprint in Cambridge
International biotechnology company GlaxoSmithKline is moving its vaccine and infectious disease research teams to Cambridge, ...